propargyl ether

structure in first source

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

1.	Carcinogenesis 09/01/2018 - "The present study investigates the 1,3-benzodioxole and its propargyl ether derivatives as a novel histone deacetylase enzyme inhibitor in order to cure cancer, as aberrant expression of histone deacetylases (HDACs) is associated with carcinogenesis. "
2.	Neoplasms (Cancer) 09/01/2018 - "Preclinical evaluation and molecular docking of 1,3-benzodioxole propargyl ether derivatives as novel inhibitor for combating the histone deacetylase enzyme in cancer." 09/01/2018 - "The present study investigates the 1,3-benzodioxole and its propargyl ether derivatives as a novel histone deacetylase enzyme inhibitor in order to cure cancer, as aberrant expression of histone deacetylases (HDACs) is associated with carcinogenesis. "

1.	Histone Deacetylases (Histone Deacetylase)
2.	Enzyme Inhibitors (Inhibitors, Enzyme)
3.	1,3-benzodioxole
4.	Enzymes